抗菌肽
抗菌剂
药品
计算生物学
抗生素耐药性
抗生素
抗药性
合理设计
生化工程
生物
纳米技术
风险分析(工程)
计算机科学
工程类
医学
药理学
微生物学
材料科学
作者
Paolo Rossetti,Marius F.W. Trollmann,Christina Wichmann,Thomas Gutsmann,Christian Eggeling,Rainer A. Böckmann
出处
期刊:Small
[Wiley]
日期:2025-06-17
标识
DOI:10.1002/smll.202411476
摘要
Abstract The United Nations have committed to end the epidemics of communicable diseases by 2030 (SDG Target 3.3). In contrast with this ambition, the rise of Multi Drug Resistant (MDR) and Pan Drug Resistant (PDR) bacteria poses a threat of a return to the pre‐antibiotic era. It is of high priority to find new therapies that target the ESKAPEE group of pathogens and their drug‐resistant strains. Antimicrobial peptides (AMPs) are an emerging class of antibiotics that hold promises of overcoming bacterial resistance by using both novel mechanisms of action as well as targeting already known pathways. The chemical space of AMPs is potentially huge and methodologies allowing the rational exploration of novel structures are highly needed. This review focuses on case studies that give novel insights about the mechanisms of action, resistance and selectivity of some relevant AMPs, exemplifying the importance of microscopic, computational and experimental tools. Particular focus will be devoted to bacterial membranes and how AMPs can target them while sparing human plasma membranes, in order to become safer drugs. The lessons learned from the literature cases give directions toward the development of AMPs as drug products.
科研通智能强力驱动
Strongly Powered by AbleSci AI